FDA.reportPublic FDA data

betamethasone 0.001 MG/MG / clioquinol 0.03 MG/MG Topical Ointment

RxCUI
106242
RxNorm name
betamethasone 0.001 MG/MG / clioquinol 0.03 MG/MG Topical Ointment
Term type
SCD
Status
Active
Updated
2026-09-09 14:38:39

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042005
Active start
042005
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
betamethasone valerate0.001 MG / 1 MGbetamethasonebetamethasone valerate
clioquinol0.03 MG / 1 MGclioquinolclioquinol

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Ointment316985

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
betamethasone1514
clioquinol5942

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRbetamethasone 0.001 MG/MG / clioquinol 0.03 MG/MG Topical Ointment1NAMES
RxNorm Namebetamethasone 0.001 MG/MG / clioquinol 0.03 MG/MG Topical Ointment1NAMES
RxNorm Synonymbetamethasone (as betamethasone valerate) 0.1 % / clioquinol 3 % Topical Ointment1NAMES
TTYSCD1ATTRIBUTES
RxCUI1062421CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS02AAAntiinfectivesATC1-4clioquinol
ATCC05AACorticosteroidsATC1-4betamethasone
ATCS03BACorticosteroidsATC1-4betamethasone
ATCS02BACorticosteroidsATC1-4betamethasone
ATCR01ADCorticosteroidsATC1-4betamethasone
ATCA07EACorticosteroids acting locallyATC1-4betamethasone
ATCS01BACorticosteroids, plainATC1-4betamethasone
ATCD07ACCorticosteroids, potent (group III)ATC1-4betamethasone
ATCD07XCCorticosteroids, potent, other combinationsATC1-4betamethasone
ATCS01CBCorticosteroids/antiinfectives/mydriatics in combinationATC1-4betamethasone
ATCR03BAGlucocorticoidsATC1-4betamethasone
ATCH02ABGlucocorticoidsATC1-4betamethasone
ATCP01AAHydroxyquinoline derivativesATC1-4clioquinol
ATCD09AAMedicated dressings with antiinfectivesATC1-4clioquinol
ATCG01ACQuinoline derivativesATC1-4clioquinol
ATCD08AHQuinoline derivativesATC1-4clioquinol
FDASPLD000485AllergensCHEMhas_chemical_structureclioquinol
FDASPLN0000175576CorticosteroidEPChas_epcbetamethasone
FDASPLN0000185508Standardized Chemical AllergenEPChas_epcclioquinol
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moabetamethasone
FDASPLN0000184306Cell-mediated ImmunityPEhas_peclioquinol
FDASPLN0000175629Increased Histamine ReleasePEhas_peclioquinol
MEDRTD001623BetamethasoneCHEMhas_ingredientbetamethasone
MEDRTD007464ClioquinolCHEMhas_ingredientclioquinol
MEDRTD017486Acneiform EruptionsDISEASEmay_treatclioquinol
MEDRTD003872DermatitisDISEASEmay_treatclioquinol
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatbetamethasone
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatbetamethasone
MEDRTD004342Drug HypersensitivityDISEASEci_withclioquinol
MEDRTD004342Drug HypersensitivityDISEASEci_withbetamethasone
MEDRTD005148Facial DermatosesDISEASEmay_treatbetamethasone
MEDRTD005499FolliculitisDISEASEmay_treatclioquinol
MEDRTD005533Foot DermatosesDISEASEmay_treatbetamethasone
MEDRTD006229Hand DermatosesDISEASEmay_treatbetamethasone
MEDRTD007249InflammationDISEASEmay_treatbetamethasone
MEDRTD007868Leg DermatosesDISEASEmay_treatbetamethasone
MEDRTD017512Lichenoid EruptionsDISEASEmay_treatclioquinol
MEDRTD009181MycosesDISEASEci_withbetamethasone
MEDRTD011538Pruritus AniDISEASEmay_treatbetamethasone
MEDRTD011565PsoriasisDISEASEmay_treatbetamethasone
MEDRTD016553Purpura, Thrombocytopenic, IdiopathicDISEASEci_withbetamethasone
MEDRTD012536Scalp DermatosesDISEASEmay_treatbetamethasone
MEDRTD014008Tinea PedisDISEASEmay_treatclioquinol
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moabetamethasone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moabetamethasone
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moaclioquinol
MEDRTN0000008297Antipruritic ActivityPEhas_pebetamethasone
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pebetamethasone
MEDRTN0000009928Decreased Cellular MigrationPEhas_pebetamethasone
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pebetamethasone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pebetamethasone
MEDRTN0000008700Decreased Lysosomal FunctionPEhas_pebetamethasone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pebetamethasone
MEDRTN0000008841Decreased Protein SynthesisPEhas_pebetamethasone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pebetamethasone
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pebetamethasone
MEDRTN0000009925Unknown Physiological EffectPEhas_peclioquinol

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
CODESSNOMEDCT331852009
NAMESPrescribable Synonymbetamethasone 0.1 % / clioquinol 3 % Topical Ointment
SOURCESSourceUS Edition of SNOMED_CT